Spyre Therapeutics, Inc.
USD100.23
+6.11 (+6.49%)
CEO
Cameron Turtle
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$92.89
Prev. Close
$94.12
Day Low
$92.37
Day High
$101.37
52W Low
$14.51
52W High
$105.09
Market Cap
$6.05B
Volume
1.09M
| 5,775 |
| $87.55 |
| 2 Jul 2026 | Burrows Scott L | Chief Financial Officer | S-Sale | Disposed | 1,725 | $88.37 |
| 2 Jul 2026 | Burrows Scott L | Chief Financial Officer | M-Exempt | Disposed | 7,500 | $14.50 |
| 2 Jul 2026 | Sloan Sheldon | Chief Medical Officer | M-Exempt | Acquired | 8,334 | $27.46 |
| 2 Jul 2026 | Sloan Sheldon | Chief Medical Officer | S-Sale | Disposed | 6,500 | $87.52 |
| 2 Jul 2026 | Sloan Sheldon | Chief Medical Officer | S-Sale | Disposed | 1,834 | $88.34 |
| 2 Jul 2026 | Sloan Sheldon | Chief Medical Officer | M-Exempt | Disposed | 8,334 | $27.46 |
| 2 Jul 2026 | Turtle Cameron | director, officer: Chief Executive Officer | S-Sale | Disposed | 10,176 | $87.44 |
| 2 Jul 2026 | Turtle Cameron | director, officer: Chief Executive Officer | S-Sale | Disposed | 4,234 | $88.12 |